XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Numerator
Net increase (decrease) in net assets resulting from operations$27,967 $53,202 $217,306 $39,548 
Less: Total distributions declared(72,534)(63,950)(204,687)(181,825)
Total Earnings (loss), net of total distributions(44,567)(10,748)12,619 (142,277)
 
Earnings (loss), net of distributions attributable to common shares(44,567)(10,748)12,486 (142,277)
Add: Distributions declared attributable to common shares71,860 63,421 202,556 180,114 
Numerator for basic and diluted change in net assets per common share$27,293 $52,673 $215,042 $37,837 
 
Denominator
Basic weighted average common shares outstanding146,899127,484141,223123,379
Common shares issuable2111,8509031,388
Weighted average common shares outstanding assuming dilution147,110129,334142,126124,767
 
Change in net assets per common share:
Basic$0.19 $0.41 $1.52 $0.31 
Diluted$0.19 $0.41 $1.51 $0.30 
Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and nine months ended September 30, 2023, and 2022, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Anti-dilutive Securities2023202220232022
Unvested common stock options3478651,7821,725
Restricted stock units5,810
Unvested restricted stock awards3953,98240,0341,611